Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-Proline is the D-enantiomer of proline, a five-membered cyclic amino acid and a member of the non-proteinogenic amino acids. Unlike L-proline (the naturally occurring form in proteins), D-proline is less common in nature but can be found in certain seeds and microbial systems. It serves as an important chiral intermediate and reagent in asymmetric synthesis for pharmaceuticals—especially antibiotics, antitumor agents, antiviral drugs—and peptide-based drug development. Its unique stereochemistry allows chemists to create molecules with specific biological activities and improved pharmacological profiles. In biological systems, it participates in some metabolic pathways and may influence protein structure when incorporated into peptides[1][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on d-proline.